Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation

References

• BenjaminEJWolfPAD’AgostinoRBSilbershatzHKannelWBLevyDImpact of atrial fibrillation on the risk of death: the Framingham Heart StudyCirculation199898109469529737513
   PubMed Web of Science ®Google Scholar
• DulliDAStankoHLevineRLAtrial fibrillation is associated with severe acute ischemic strokeNeuroepidemiology2002234118123
   Google Scholar
• WangTJLarsonMGLevyDVasanRSTemporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart StudyCirculation200310772920292512771006
   PubMed Web of Science ®Google Scholar
• WolfPAAbbottRDKannelWBAtrial fibrillation as an independent risk factor for stroke: the Framingham StudyStroke19912289839881866765
   PubMed Web of Science ®Google Scholar
• WyseDGSleeAEpsteinAEAlternative endpoints for mortality in studies of patients with atrial fibrillation: the AFFIRM study experienceHeart Rhythm200451153153715851214
   PubMed Web of Science ®Google Scholar
• StewartSHartCLHoleDJMcMurrayJJA population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley studyAm J Med2002113535936412401529
   PubMed Web of Science ®Google Scholar
• FusterVRydénLECannomDSACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillationEuropace20068965174516987906
   PubMed Web of Science ®Google Scholar
• FusterVRydénLECannomDSACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy ConferencesJ Am Coll Cardiol200648885490616904574
   PubMed Web of Science ®Google Scholar
• GoASHylekEMPhillipsKAPrevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyJAMA200128552370237511343485
   PubMed Web of Science ®Google Scholar
• CammJAReiffelJADefining endpoints in clinical trials on atrial fibrillationEur Heart J Suppl200810Suppl HH5578
   Web of Science ®Google Scholar
• NaccarelliGVVarkerHLinJSchulmanKLIncreasing prevalence of atrial fibrillation and flutter in the United StatesAm J Cardiol2009104121534153919932788
   PubMed Web of Science ®Google Scholar
• NattelSCarlssonLInnovative approaches to anti-arrhythmic drug therapyNat Rev Drug Discov20065121034104917139288
   PubMed Web of Science ®Google Scholar
• NattelSOpieLHControversies in atrial fibrillationLancet2006367950626227216427496
   PubMed Web of Science ®Google Scholar
• NattelSNew ideas about atrial fibrillation 50 years onNature2002415686821922611805846
   PubMed Web of Science ®Google Scholar
• NattelSBursteinBDobrevDAtrial remodeling and atrial fibrillation: mechanisms and implicationsCirc Arrhythmia Electrophysiol2008116273
   PubMed Web of Science ®Google Scholar
• AllessieMABonkeFISchopmanFJCircus movement in rabbit atrial muscle as a mechanism of tachycardia III. The “leading circle” concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacleCirc Res1977411918862147
   PubMed Web of Science ®Google Scholar
• ComtoisPKnellerJNattelSOf circles and spirals: bridging the gap between the leading circle and spiral wave concepts of cardiac reentryEuropace20057suppl 2102016102499
   PubMed Web of Science ®Google Scholar
• DavidenkoJMPertsovAVSalomonszRBaxterWJalifeJStationary and drifting spiral waves of excitation in isolated cardiac muscleNature199235563583493511731248
   PubMed Web of Science ®Google Scholar
• PertsovAMDavidenkoJMSalomonszRBaxterWTJalifeJSpiral waves of excitation underlie reentrant activity in isolated cardiac muscleCirc Res19937236316508431989
   PubMed Web of Science ®Google Scholar
• DobrevDNattelSNew antiarrhythmic drugs for treatment of atrial fibrillationLancet201037597211212122320334907
   PubMed Web of Science ®Google Scholar
• HartRGPearceLAAguilarMIMeta-analysis: antithrombotic therapy to prevent stroke in patients who have non-valvular atrial fibrillationAnn Intern Med20071461285786717577005
   PubMed Web of Science ®Google Scholar
• CarlssonJMiketicSWindelerJRandomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) studyJ Am Coll Cardiol20034151690169612767648
   PubMed Web of Science ®Google Scholar
• HohnloserSHKuckKHLilienthalJRhythm or rate control in atrial fibrillation–Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomized trialLancet2000356111789179411117910
   PubMed Web of Science ®Google Scholar
• Van GelderICHagensVEBoskerHAA comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillationN Engl J Med2002347111834184012466507
   PubMed Web of Science ®Google Scholar
• WyseDGWaldoALDiMarcoJPAtrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillationN Engl J Med2002347121825183312466506
   PubMed Web of Science ®Google Scholar
• EchtDSLiebsonPRMitchellLBMortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression TrialN Engl J Med199132437817881900101
   PubMed Web of Science ®Google Scholar
• CammAJKirchhofPLipGYGuidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)Eur Heart J201031192369242920802247
   PubMed Web of Science ®Google Scholar
• EhrlichJRNattelSHohnloserSHNovel anti-arrhythmic drugs for atrial fibrillation managementCurr Vasc Pharmacol20075318519517627562
   PubMed Web of Science ®Google Scholar
• OyetayoOORogersCEHofmannPODronedarone: a new antiarrhythmic agentPharmacotherapy201030990491520795846
   PubMed Web of Science ®Google Scholar
• KathöferSThomasDKarleCAThe novel antiarrhythmic druc dronedarone: comparison with amiodaroneCardiovasc Drug Rev200523321723016252015
   PubMed Web of Science ®Google Scholar
• PatelPDBhuriyaRPatelDDAroraBLSinghPPAroraRRDronedarone for atrial fibrillation: a new therapeutic agentVasc Health Risk Manag2009563564219688104
   PubMedGoogle Scholar
• SunWSarmaJSSinghBNChronic and acute effects of dronedarone on the action potential of rabbit atrial muscle preparations: comparison with amiodaroneJ Cardiovasc Pharmacol200239567768411973411
   PubMed Web of Science ®Google Scholar
• ThomasDKathoferSZhangWAcute effects of dronedarone on both components of the cardiac delayed rectifier K+ current, HERG and KvLQT1/minK potassium channelsBr J Pharmacol20031405996100214517175
   PubMed Web of Science ®Google Scholar
• GautierPGuillemareEMarionABertrandJPTourneurYNisatoDElectrophysiologic characterization of dronedarone in guinea pig ventricular cellsJ Cardiovasc Pharmacol200341219120212548079
   PubMed Web of Science ®Google Scholar
• HodeigeDHeyndrickxJPChatelainPManningASR 33589, a new amiodarone-like antiarrhythmic agent: anti-adrenoceptor activity in anaesthetized and conscious dogsEur J Pharmacol1995279625327556379
   PubMed Web of Science ®Google Scholar
• GuiraudouPPucheuSCGayraudRInvolvement of nitric oxide in amiodarone- and dronedarone-induced coronary vasodilation in guinea pig heartEur J Pharmacol2004496811912715288583
   PubMed Web of Science ®Google Scholar
• TouboulPBrugadaJCapucciACrijnsHJEdvardssonNHohnloserSHDronedarone for prevention of atrial fibrillation: a dose-ranging studyEur Heart J20032481481148712919771
   PubMed Web of Science ®Google Scholar
• PollakPTShaferSLUse of population modeling to define rational monitoring of amiodarone hepatic effectsClin Pharmacol Ther200475434235115060512
   PubMed Web of Science ®Google Scholar
• TschuppertYBuclinTRothuizenLEEffect of dronedarone on renal function in healthy subjectsBr J Clin Pharmacol2007641278579117662087
   PubMed Web of Science ®Google Scholar
• SinghBNConnollySJCrijnsHJDronedarone for maintenance of sinus rhythm in atrial fibrillation or flutterN Engl J Med2007357998799917804843
   PubMed Web of Science ®Google Scholar
• DavyJMHeroldMHoglundCERATO Study InvestigatorsDronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) studyAm Heart J20081569527.e1e918760136
   PubMed Web of Science ®Google Scholar
• KøberLTorp-PedersenCMcMurrayJJIncreased mortality after dronedarone therapy for severe heart failureN Engl J Med200835862678268718565860
   PubMed Web of Science ®Google Scholar
• HohnloserSHCrijnsHJvan EickelsMEffect of dronedarone on cardiovascular events in atrial fibrillationN Engl J Med2009360266867819213680
   PubMed Web of Science ®Google Scholar
• ConnollySJCrijnsHJTorp-PedersenCAnalysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutterCirculation200912091174118019752319
   PubMed Web of Science ®Google Scholar
• Torp-PedersenCPageRLConnollySThe effect of dronedarone on hospitalizations in patients with atrial fibrillation. Results from the ATHENA studyCirculation2008118882818678771
   PubMed Web of Science ®Google Scholar
• PageRLConnollySCrijnsHRhythm- and rate-controlling of dronedarone in patients with atrial fibrillation. Results from the ATHENA trialCirculation20081188827
   Google Scholar
• Le HeuzeyJYDe FerrariGMRadzikDSantiniMZhuJDavyJMA short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS studyJ Cardiovasc Electrophysiol201021659760520384650
   PubMed Web of Science ®Google Scholar
• BongardVMarcDPhilippeVJean-LouisMMaryseLMIncidence rate of adverse drug reactions during long-term follow-up of patients newly treated with amiodaroneAm J Ther20061378315319
   Google Scholar
• PicciniJPHasselbladVPetersonEDWashamJBCaliffRMKongDFComparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillationJ Am Coll Cardiol200954121089109519744618
   PubMed Web of Science ®Google Scholar
• HughesPJFreemanMKCohenourFVPriceEMDronedarone: an alternative to amiodarone?Consult Pharm201025955556920876046
   PubMedGoogle Scholar
• WolbretteDGonzalezMSamiiSBanchsJPenny-PetersonENaccarelliGDronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacyVasc Health Risk Manag2010651752320730068
   PubMedGoogle Scholar
• DoyleJFHoKMBenefits and risks of long-term amiodarone therapy for persistent atrial fibrillation: a meta-analysisMayo Clin Proc200984323424219252110
   PubMed Web of Science ®Google Scholar